These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23320520)

  • 21. Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
    Kinoshita Y; Sakurai Y; Shiino M; Kudou K; Nishimura A; Miyagi T; Iwakiri K; Umegaki E; Ashida K
    Curr Ther Res Clin Exp; 2016; 81-82():1-7. PubMed ID: 28119763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteers.
    Sjögren E; Ståhle L; Quiding H; Jonzon B; Halldin MM; Sundgren AK
    Eur J Pain; 2019 Nov; 23(10):1767-1779. PubMed ID: 31314954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux: A Meta-Analysis of Randomized Controlled Trials.
    Guo H; Ma H; Wang J
    J Clin Gastroenterol; 2016 Apr; 50(4):295-300. PubMed ID: 25906028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
    Kinoshita Y; Sakurai Y; Takabayashi N; Kudou K; Araki T; Miyagi T; Iwakiri K; Ashida K
    Clin Transl Gastroenterol; 2019 Nov; 10(11):e00101. PubMed ID: 31770139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms.
    Kim JJ; Kim N; Choi YJ; Kim JS; Jung HC
    Medicine (Baltimore); 2016 Aug; 95(32):e4387. PubMed ID: 27512850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial.
    Kondo T; Sei H; Yamasaki T; Tomita T; Ohda Y; Oshima T; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2017 Oct; 52(10):1081-1089. PubMed ID: 28120127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Effects of Red Chili, a Natural Capsaicin Receptor Agonist, on Gastric Accommodation and Upper Gastrointestinal Symptoms in Healthy Volunteers and Gastroesophageal Reflux Disease Patients.
    Patcharatrakul T; Kriengkirakul C; Chaiwatanarat T; Gonlachanvit S
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amiloride on experimental acid-induced heartburn in non-erosive reflux disease.
    Bulsiewicz WJ; Shaheen NJ; Hansen MB; Pruitt A; Orlando RC
    Dig Dis Sci; 2013 Jul; 58(7):1955-9. PubMed ID: 23649374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease.
    Silva RO; Bingana RD; Sales TMAL; Moreira RLR; Costa DVS; Sales KMO; Brito GAC; Santos AA; Souza MÂN; Soares PMG; Sifrim D; Souza MHLP
    Neurogastroenterol Motil; 2018 Mar; ():e13340. PubMed ID: 29573069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trial.
    Zhang X; Cheng Y; Li X; Tan X; Shi L; Shi X; Zhang X; Xie C; Li J
    Trials; 2021 Aug; 22(1):545. PubMed ID: 34407832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep).
    Manitpisitkul P; Flores CM; Moyer JA; Romano G; Shalayda K; Tatikola K; Hutchison JS; Mayorga AJ
    Scand J Pain; 2018 Apr; 18(2):151-164. PubMed ID: 29794306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial.
    Odaka T; Yamato S; Yokosuka O
    Curr Ther Res Clin Exp; 2017; 84():37-41. PubMed ID: 28761578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease.
    Yoshida N; Kuroda M; Suzuki T; Kamada K; Uchiyama K; Handa O; Takagi T; Yoshikawa T; Kuramoto H
    Dig Dis Sci; 2013 Aug; 58(8):2237-43. PubMed ID: 22899239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reconsidering on the drug therapy of adult laryngopharyngeal reflux disease].
    Hu JJ; Zheng MJ; Chen Y; Yu LY; Yang H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):635-639. PubMed ID: 30122007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.
    Khan Z; Alastal Y; Khan MA; Khan MS; Khalil B; Shrestha S; Kamal F; Nawras A; Howden CW
    Gastroenterol Res Pract; 2018; 2018():6417526. PubMed ID: 30158966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a new nutraceutical formulation (CHETOGERD
    Fiorini G; Saracino IM; Pavoni M; Saccomanno L; Vaira D
    Intern Emerg Med; 2020 Oct; 15(7):1265-1269. PubMed ID: 32198722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.
    Schaffler K; Reeh P; Duan WR; Best AE; Othman AA; Faltynek CR; Locke C; Nothaft W
    Br J Clin Pharmacol; 2013 Feb; 75(2):404-14. PubMed ID: 22775239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials.
    McQuaid KR; Laine L
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):553-63. PubMed ID: 15952097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis.
    Garami A; Shimansky YP; Rumbus Z; Vizin RCL; Farkas N; Hegyi J; Szakacs Z; Solymar M; Csenkey A; Chiche DA; Kapil R; Kyle DJ; Van Horn WD; Hegyi P; Romanovsky AA
    Pharmacol Ther; 2020 Apr; 208():107474. PubMed ID: 31926897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease.
    Kim SH; Cho KB; Chun HJ; Lee SW; Kwon JG; Lee DH; Kim SG; Jung HY; Kim JW; Lee JS; Park H; Choi SC; Jee SR; Kim HS; Ko KH; Park SJ; Lee YC; Park SH; Kim AR; Kim EJ; Park HW; Kim BT; Song GS
    Aliment Pharmacol Ther; 2021 Aug; 54(4):402-411. PubMed ID: 34227708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.